Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1982 Mar 1;201(3):629–633. doi: 10.1042/bj2010629

A fibronectin-binding glycoprotein from human platelet membranes.

M S Hansen, I Clemmensen
PMCID: PMC1163690  PMID: 6284125

Abstract

Fibronectin ('cold-insoluble globulin') has been suggested as a possible mediator of platelet adhesion. A fibronectin-binding protein as partially purified from washed solubilized human platelet membranes by affinity chromatography on fibronectin-Sepharose. The isolated protein migrated as a single band on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis with an Mr (relative molecular mass) of approx. 125 000 under reducing conditions. The protein migrated as a dimer in non-reduced gels. The purified protein did not react with immunoglobulins against fibrinogen or fibronectin when tested in crossed immunoelectrophoresis or electroimmunoassay. The protein and purified fibronectin formed a complex that had a significantly faster mobility in crossed immunoelectrophoresis than did native fibronectin. The presence of heparin in the binding-protein-fibronectin mixture resulted in an even faster mobility of the complex, whereas the mobility of native fibronectin was unaffected. Crossed affinoimmunoelectrophoresis of the complex using different lectins suggested that the binding protein is a glycoprotein containing N-acetylglucosamine residues. The complex, but not purified fibronectin, bound to phenyl-Sepharose on crossed hydrophobic-interaction immunoelectrophoresis. The results strongly suggest the presence of a fibronectin-binding glycoprotein in the platelet membrane.

Full text

PDF
629

Images in this article

630Fig. 1.
on p.630
631Fig. 2.
on p.631
631Fig. 3.
on p.631
632Fig. 4.
on p.632

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arneson M. A., Hammerschmidt D. E., Furcht L. T., King R. A. A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function. JAMA. 1980 Jul 11;244(2):144–147. [PubMed] [Google Scholar]
  2. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  3. Bang N. U., Hansen M. S., Smith G. F., Mosesson M. W. Properties of soluble fibrin polymers encountered in thrombotic states. Thromb Diath Haemorrh Suppl. 1973;56:75–90. [PubMed] [Google Scholar]
  4. Barber A. J., Jamieson G. A. Isolation and characterization of plasma membranes from human blood platelets. J Biol Chem. 1970 Dec 10;245(23):6357–6365. [PubMed] [Google Scholar]
  5. Bensusan H. B., Koh T. L., Henry K. G., Murray B. A., Culp L. A. Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5864–5868. doi: 10.1073/pnas.75.12.5864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bjerrum O. J. Crossed hydrophobic interaction immunoelectrophoresis: an analytical method for detection of amphiphilic proteins in crude mixtures and for prediction of the result of hydrophobic interaction chromatography. Anal Biochem. 1978 Oct 1;90(1):331–348. doi: 10.1016/0003-2697(78)90036-2. [DOI] [PubMed] [Google Scholar]
  7. Cheng C. M., Hawiger J. Affinity isolation and characterization of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets. J Biol Chem. 1979 Apr 10;254(7):2165–2167. [PubMed] [Google Scholar]
  8. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  9. Ginsberg M. H., Painter R. G., Forsyth J., Birdwell C., Plow E. F. Thrombin increases expression of fibronectin antigen on the platelet surface. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1049–1053. doi: 10.1073/pnas.77.2.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gralnick H. R. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity. J Clin Invest. 1978 Aug;62(2):496–499. doi: 10.1172/JCI109152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jilek F., Hörmann H. Fibronectin (cold-insoluble globulin), V[1]. Mediation of fibrin-monomer binding to macrophages. Hoppe Seylers Z Physiol Chem. 1978 Nov;359(11):1603–1605. [PubMed] [Google Scholar]
  12. Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature. 1978 Dec 14;276(5689):718–720. doi: 10.1038/276718a0. [DOI] [PubMed] [Google Scholar]
  13. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  14. Majerus P. W., Miletich J. P. Relationships between platelets and coagulation factors in hemostasis. Annu Rev Med. 1978;29:41–49. doi: 10.1146/annurev.me.29.020178.000353. [DOI] [PubMed] [Google Scholar]
  15. Mosher D. F., Proctor R. A. Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science. 1980 Aug 22;209(4459):927–929. doi: 10.1126/science.7403857. [DOI] [PubMed] [Google Scholar]
  16. Müllertz S., Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J. 1976 Dec 1;159(3):545–553. doi: 10.1042/bj1590545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nurden A. T., Caen J. P. Specific roles for platelet surface glycoproteins in platelet function. Nature. 1975 Jun 26;255(5511):720–722. doi: 10.1038/255720a0. [DOI] [PubMed] [Google Scholar]
  18. Plow E. F., Birdwell C., Ginsberg M. H. Identification and quantitation of platelet-associated fibronectin antigen. J Clin Invest. 1979 Mar;63(3):540–543. doi: 10.1172/JCI109334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saba T. M., Blumenstock F. A., Weber P., Kaplan J. E. Physiologic role of cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic alpha 2-surface-binding glycoprotein. Ann N Y Acad Sci. 1978 Jun 20;312:43–55. doi: 10.1111/j.1749-6632.1978.tb16792.x. [DOI] [PubMed] [Google Scholar]
  20. Sandbjerg Hansen M., Clemmensen I. Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors. Biochem J. 1980 Apr 1;187(1):173–180. doi: 10.1042/bj1870173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sochynsky R. A., Boughton B. J., Burns J., Sykes B. C., McGee J. O. The effect of human fibronectin on platelet-collagen adhesion. Thromb Res. 1980 May 1;18(3-4):521–533. doi: 10.1016/0049-3848(80)90348-5. [DOI] [PubMed] [Google Scholar]
  22. Stathakis N. E., Mosesson M. W. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J Clin Invest. 1977 Oct;60(4):855–865. doi: 10.1172/JCI108840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vaheri A., Mosher D. F. High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta. 1978 Sep 18;516(1):1–25. doi: 10.1016/0304-419x(78)90002-1. [DOI] [PubMed] [Google Scholar]
  24. Zucker M. B., Mosesson M. W., Broekman M. J., Kaplan K. L. Release of platelet fibronectin (cold-insoluble globulin) from alpha granules induced by thrombin or collagen; lack of requirement for plasma fibronectin in ADP-induced platelet aggregation. Blood. 1979 Jul;54(1):8–12. [PubMed] [Google Scholar]
  25. Zwaal R. F. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta. 1978 Jul 31;515(2):163–205. doi: 10.1016/0304-4157(78)90003-5. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES